Baidu
map

医疗机器人ARES通过FDA批准

2016-06-15 佚名 搜狐

据消息,FDA 在 2016年5月底批准了医疗机器人 ARES(Auris Robotic Endoscopy System 的缩写),它现在可以用于诊断和治疗病人。  Auris,仅仅将自己描述为 “总部设在硅谷的技术公司”,以前被人以为做的是显微外科手术系统,旨在消除白内障,该公司还提交了多项专利申请。然而,很多员工调查后发现,它有着更大的野心——构建下一代外科手术机器人,扩大机器人的适用范围

据消息,FDA 在 2016年5月底批准了医疗机器人 ARES(Auris Robotic Endoscopy System 的缩写),它现在可以用于诊断和治疗病人。
  
Auris,仅仅将自己描述为 “总部设在硅谷的技术公司”,以前被人以为做的是显微外科手术系统,旨在消除白内障,该公司还提交了多项专利申请。然而,很多员工调查后发现,它有着更大的野心——构建下一代外科手术机器人,扩大机器人的适用范围。
  
仔细阅读Auris 的科学家提交的专利申请可以看到,该公司专注于腔内手术。这需要外科医生利用灵活的机器人通过身体的自然开口(特别是嘴),来治疗喉咙、肺和胃肠道系统的疾病。
  
因为内镜下手术不需要大切口,或(通常)全身麻醉,ARES 可以使内窥镜检查手术更容易,从而造福那些在常规手术中不能承受创伤的虚弱病人。外科医生会对设备进行远程控制,并能看到安装在内窥镜上的微型摄像机所拍摄的图像。这就不再需要依赖外部成像(如 CT 扫描或 X 线透视),就能引导内窥镜了。
  
目前,Auris 已经在美国以外的国家至少成功进行了一次由机器人操作的人体手术。
  

  
美国胃肠道和内镜医师协会( The Society for American Gastrointestinal and Endoscopic Surgeons)曾估计,在美国,单对肥胖与反流性疾病进行有效的内镜下治疗,每年能帮助 100 万多名病人。
  
值得一提的是,Auris 是 Frederic Moll 博士创立的第四家手术机器人公司,Moll 也是 Intuitive Surgical 公司 ($ISRG) 的联合创始人,后者生产了著名的达芬奇手术机器人。2016年4月,Intuitive Surgical 宣布以 8000 万美元收购了 Moll 创立的另一家公司 Hansen Medical。
  
此外,许多其他玩家也在研究 Intuitive 的能力。美敦力($ MDT)日前透露,它正在着手于它的第十个手术机器人的模型研发,早的话可以在 2018年推出,并在 2019年产生实际收入;强生公司(Johnson & Johnson,$JNJ)在 2015年与 Verily 成立了一个机器人合资公司 Verb Surgical。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1839447, encodeId=671a183944ecc, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Oct 10 00:22:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90283, encodeId=f9179028330, content=精准手术, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5b11304786, createdName=ljh0111, createdTime=Sat Jun 18 00:54:00 CST 2016, time=2016-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321887, encodeId=95ae132188e15, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582951, encodeId=01d7158295186, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=)]
    2016-10-10 bugit
  2. [GetPortalCommentsPageByObjectIdResponse(id=1839447, encodeId=671a183944ecc, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Oct 10 00:22:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90283, encodeId=f9179028330, content=精准手术, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5b11304786, createdName=ljh0111, createdTime=Sat Jun 18 00:54:00 CST 2016, time=2016-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321887, encodeId=95ae132188e15, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582951, encodeId=01d7158295186, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=)]
    2016-06-18 ljh0111

    精准手术

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1839447, encodeId=671a183944ecc, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Oct 10 00:22:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90283, encodeId=f9179028330, content=精准手术, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5b11304786, createdName=ljh0111, createdTime=Sat Jun 18 00:54:00 CST 2016, time=2016-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321887, encodeId=95ae132188e15, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582951, encodeId=01d7158295186, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=)]
    2016-06-17 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1839447, encodeId=671a183944ecc, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7311, encryptionId=341ae311ea, topicName=FDA批准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Mon Oct 10 00:22:00 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=90283, encodeId=f9179028330, content=精准手术, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5b11304786, createdName=ljh0111, createdTime=Sat Jun 18 00:54:00 CST 2016, time=2016-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321887, encodeId=95ae132188e15, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582951, encodeId=01d7158295186, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Fri Jun 17 04:22:00 CST 2016, time=2016-06-17, status=1, ipAttribution=)]

相关资讯

Sci Transl Med:更完美的医疗机器人

国哈佛大学工程和应用科学学院教授,Wyss 生物启发工程研究所核心创始成员Robert Wood 等近日在《科学—转化医学》刊文,畅想未来医疗机器人的发展走向。 在科幻小说中,机器人通常被描绘成拥有类似人类的智力和能力,并且以一种自然、拟人化的方式来和人类互动。 近年来,生产机器人产品所发展出来的机器人核心技术(如传感器、执行器、控制算法和机构学)是人们负担得起并且可以获得的,这些技术正在渗透

Baidu
map
Baidu
map
Baidu
map